Rsdl
Ended Awarded Last action
- Contract number
- SPE2D626F11R8
- Awardee
-
Canadian Commercial Corporation UEI FA38CTVQM319
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,954,436
Award facts
- Contract value 100% obligated
- $2,954,435.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain division awarded a $2.95 million delivery order to Canadian Commercial Corporation on December 11, 2025, for the procurement and delivery of Reactive Skin Decontamination Lotion (RSDL). This delivery order, which represents a child contract action, carries no set-aside designation and is scheduled for completion by February 27, 2026. Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, serves as the prime contractor and government-to-government intermediary facilitating defense procurement between U.S. federal agencies and Canadian manufacturers. The actual manufacturing of the RSDL product is being performed by Emergent Biosolutions Canada Inc., a subcontractor specializing in medical countermeasures and therapeutics for chemical, biological, radiological, and nuclear threats.
RSDL is a specialized decontamination product used by military personnel to remove chemical and biological contaminants from skin. Emergent Biosolutions Canada Inc. brings significant expertise in this domain, having supplied skin decontamination lotion to the Defense Logistics Agency through prior federal contracts and maintaining substantial experience in medical countermeasures valued at over $770 million across its federal contract portfolio. The work will be performed at Canadian Commercial Corporation's headquarters in Ottawa, Ontario, reflecting the government-to-government nature of this procurement and the strategic importance of maintaining supply chain access to Canadian manufacturing capabilities for critical military medical supplies.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Emergent Biosolutions Canada Inc. | $0 |
Quick answers
Who was awarded contract SPE2D626F11R8?
SPE2D626F11R8 was awarded to Canadian Commercial Corporation by Medical Supply Chain (Troop Support) on December 11, 2025.
How much is contract SPE2D626F11R8 worth?
The government has obligated $2,954,436 on SPE2D626F11R8.
Is contract SPE2D626F11R8 an order under another contract?
Yes. SPE2D626F11R8 is a delivery order under SPE2DP23D0001, an indefinite delivery contract.
Was contract SPE2D626F11R8 competed?
The extent of competition for SPE2D626F11R8 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award